Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry

Vibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, Emmanuel Prokopakis, Anette Drøhse Kjeldsen, Philippe Gevaert, Adam M. Chaker, Luisa Azevedo, Christian von Buchwald, Emilie Bequignon, Eliza Brozek-Madry, Jannis Constantinidis, Marjolein Cornet, Wytske J. Fokkens, Peter G. Gibson, Aleksander Grande Hansen, Joaquim Mullol, Sietze Reitsma, Sanna Toppila-Salmi, Michael B. Soyka, Martin Wagenmann, Peter W. Hellings

Open source

DOI
10.3389/falgy.2025.1680703
Published
2025-10-13
Container
Frontiers in Allergy
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/falgy.2025.1680703,
  title = {Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry},
  author = {Vibeke Backer and Eugenio De Corso and Geoffrey Mortuaire and Emmanuel Prokopakis and Anette Drøhse Kjeldsen and Philippe Gevaert and Adam M. Chaker and Luisa Azevedo and Christian von Buchwald and Emilie Bequignon and Eliza Brozek-Madry and Jannis Constantinidis and Marjolein Cornet and Wytske J. Fokkens and Peter G. Gibson and Aleksander Grande Hansen and Joaquim Mullol and Sietze Reitsma and Sanna Toppila-Salmi and Michael B. Soyka and Martin Wagenmann and Peter W. Hellings},
  year = {2025},
  journal = {Frontiers in Allergy},
  doi = {10.3389/falgy.2025.1680703},
  url = {https://doi.org/10.3389/falgy.2025.1680703}
}

RIS

TY  - JOUR
TI  - Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry
AU  - Vibeke Backer
AU  - Eugenio De Corso
AU  - Geoffrey Mortuaire
AU  - Emmanuel Prokopakis
AU  - Anette Drøhse Kjeldsen
AU  - Philippe Gevaert
AU  - Adam M. Chaker
AU  - Luisa Azevedo
AU  - Christian von Buchwald
AU  - Emilie Bequignon
AU  - Eliza Brozek-Madry
AU  - Jannis Constantinidis
AU  - Marjolein Cornet
AU  - Wytske J. Fokkens
AU  - Peter G. Gibson
AU  - Aleksander Grande Hansen
AU  - Joaquim Mullol
AU  - Sietze Reitsma
AU  - Sanna Toppila-Salmi
AU  - Michael B. Soyka
AU  - Martin Wagenmann
AU  - Peter W. Hellings
PY  - 2025
JO  - Frontiers in Allergy
DO  - 10.3389/falgy.2025.1680703
UR  - https://doi.org/10.3389/falgy.2025.1680703
ER  - 

APA

Backer, V., Corso, E. D., Mortuaire, G., Prokopakis, E., Kjeldsen, A. D., Gevaert, P., Chaker, A. M., Azevedo, L., Buchwald, C. V., Bequignon, E., Brozek-Madry, E., Constantinidis, J., Cornet, M., Fokkens, W. J., Gibson, P. G., Hansen, A. G., Mullol, J., Reitsma, S., Toppila-Salmi, S., Soyka, M. B., Wagenmann, M., & Hellings, P. W. (2025). Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry. Frontiers in Allergy. https://doi.org/10.3389/falgy.2025.1680703

Source records